Skip to main content

Advertisement

Log in

Prevalence of TEM, SHV, and CTX-M genes of extended-spectrum β-lactamase-producing Escherichia coli strains isolated from urinary tract infections in adults

  • Original Article
  • Published:
3 Biotech Aims and scope Submit manuscript

Abstract

Urinary tract infections (UTIs) are one of the major sources of widespread infectious diseases in the community as well as in the hospitals which increase the cause of morbidity and mortality. Prevalence of extended-spectrum-β-lactamase (ESBL)-producing uropathogenic E. coli isolates has been found to be increased rapidly across the world. The present study was undertaken to find out the frequency of bla TEM, bla CTX-M, and bla SHV genes among E. coli isolates from UTI and detect their sensitivity pattern. A total of 112 non-repeated E. coli isolates obtained from urine samples of UTI diagnosed patients were included in this study. Antibiotic susceptibility test was done by disc diffusion method. Seventy seven (68.75%) isolates were MDR and tested for ESBL. ESBL-positive isolates were screened for bla TEM, bla CTX-M, and bla SHV genes by monoplex PCR (polymerase chain reaction). Among 46 ESBL-producing E. coli isolates, 8.69% harboured all the three bla genes. The bla TEM was the predominant (93.47%) gene followed by bla CTX-M (82.6%) and bla SHV (4.34%). It can be concluded that the prevalence of MDR (multidrug resistance) ESBL-producing E. coli appears to be high and the highest identified gene was bla TEM. The knowledge of resistance pattern can help physician’s select suitable empirical antibiotic regimens, so that antibiotics showing high-resistance pattern can be avoided.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Abujnah AA, Zorgani A, Sabri MAM et al (2015) Multidrug resistance and extended-spectrum β-lactamases genes among Escherichia coli from patients with urinary tract infections in Northwestern Libya. Libyan J Med 10:26412. doi:10.3402/ljm.v10.26412

    Article  Google Scholar 

  • Adwan K, Jarrar N, Abu-Hijleh A et al (2014) Molecular characterization of Escherichia coli isolates from patients with urinary tract infections in Palestine. J Med Microbiol 63:229–234. doi:10.1099/jmm.0.067140-0

    Article  CAS  Google Scholar 

  • Bagattini M, Crivaro V, Di Popolo A et al (2006) Molecular epidemiology of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit. J Antimicrob Chemother 57:979–982. doi:10.1093/jac/dkl077

    Article  CAS  Google Scholar 

  • Bajpai T, Pandey M, Varma M, Bhatambare GS (2017) Prevalence of TEM, SHV and CTX-M beta-lactamase genes in the urinary isolates of a tertiary care hospital. Avicenna J Med 7:12–16

    Article  Google Scholar 

  • Bali EB, Açık L, Sultan N (2010) Phenotypic and molecular characterization of SHV produced by Escherichia coli, Acinobacter baumannii and Klebsiella isolates in a Turkish hospital. Afr J Microbiol Res 4:650–654

    CAS  Google Scholar 

  • Barguigua A, El Otmani F, Talmi M et al (2011) Characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from the community in Morocco. J Med Microbiol 60:1344–1352. doi:10.1099/jmm.0.032482-0

    Article  CAS  Google Scholar 

  • Bronson JJ, Barrett JF (2001) Quinolone, everninomycin, glycylcycline, carbapenem, lipopeptide and cephem antibacterials in clinical development. Curr Med Chem 8:1775–1793

    Article  CAS  Google Scholar 

  • Carattoli A, García-Fernández A, Varesi P et al (2008) Molecular epidemiology of Escherichia coli producing extended-spectrum β-lactamases isolated in Rome, Italy. J Clin Microbiol 46:103–108. doi:10.1128/JCM.01542-07

    Article  CAS  Google Scholar 

  • Chaudhary U, Aggarwal R (2004) Extended spectrum β-lactamases (ESBL)-an emerging threat to clinical therapeutics. Indian J Med Microbiol 22:75–80

    CAS  Google Scholar 

  • Daoud Z, Salem Sokhn E, Masri K et al (2015) Escherichia coli isolated from urinary tract infections of Lebanese patients between 2005 and 2012: epidemiology and profiles of resistance. Front Med 2:26. doi:10.3389/fmed.2015.00026

    Google Scholar 

  • Eckert C, Gautier V, Saladin-Allard M et al (2004) Dissemination of CTX-M-type β-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 48:1249–1255. doi:10.1128/AAC.48.4.1249-1255.2004

    Article  CAS  Google Scholar 

  • El Bouamri MC, Arsalane L, Zerouali K et al (2015) Molecular characterization of extended spectrum β-lactamase-producing Escherichia coli in a university hospital in Morocco, North Africa. Afr J Urol 21:161–166. doi:10.1016/j.afju.2015.02.005

    Article  Google Scholar 

  • Fernandes R, Amador P, Oliveira C, Prudêncio C (2014) Molecular characterization of ESBL-producing Enterobacteriaceae in northern Portugal. Sci World J. doi:10.1155/2014/782897

    Google Scholar 

  • Gonzalez CM, Schae€er AJ (1999) Treatment of urinary tract infection: what’s old, what’s new, and what works. World J Urol 17:372–382. doi:10.1007/s003450050163

    Article  CAS  Google Scholar 

  • Haque SF (2011) Extended spectrum β-lactamases mediated resistance in urinary tract infections “Changing profile at a teaching hospital of north India”. Int J Cur Bio Med Sci 1:103–107

    Google Scholar 

  • Harada Y, Morinaga Y, Yamada K et al (2013) Clinical and molecular epidemiology of extended spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli in a Japanese tertiary hospital. J Med Microbiol Diagn 2:127

    Google Scholar 

  • Hassan SA, Jamal SA, Mustafa K (2011) Occurrence of multidrug resistant and ESBL producing E. coli causing urinary tract infections. J Basic Appl Sci 7:39–43

    CAS  Google Scholar 

  • Hosoglu S, Gundes S, Kolayh F et al (2007) Extended spectrum β-lactamases in ceftazidime resistant Escherichia coli and Klebsiella pneumonia isolates in Turkish hospitals. Indian J Med Microb 25:346–350

    Article  CAS  Google Scholar 

  • Hsueh PR, Hoban DJ, Carmeli Y et al (2011) Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. J Infect 63:114–123. doi:10.1016/j.jinf.2011.05.015

    Article  Google Scholar 

  • Ibrahim ME, Bilal NE, Magzoub MA, Hamid ME (2013) Prevalence of extended-spectrum β-lactamases-producing Escherichia coli from hospitals in Khartoum State, Sudan. Oman Med J 28:116–120. doi:10.5001/omj.2013.30

    Article  CAS  Google Scholar 

  • Jena J, Debata NK, Subudhi E (2013) Prevalence of extended-spectrum-β-lactamase and metallo-β-lactamase producing multi drug resistance gram-negative bacteria from urinary isolates. Indian J Med Microbiol 31:420–421

    Article  CAS  Google Scholar 

  • Jena J, Sahoo RK, Subudhi E, Debata NK (2014) Prevalence of ESBL, MBL and Ampc-β-lactamases producing multidrug resistance gram negative bacteria in a tertiary care hospital. J Pure Appl Microbiol 8:4099–4105

    Google Scholar 

  • Manoharan A, Premalatha K, Chatterjee S, Mathai D (2011) Correlation of TEM, SHV and CTX-M extended-spectrum beta lactamases among Enterobacteriaceae with their in vitro antimicrobial susceptibility. Indian J Med Microbiol 29:161–164. doi:10.4103/0255-0857.81799

    Article  CAS  Google Scholar 

  • Moosavian M, Deiham B (2012) Distribution of TEM, SHV and CTX-M Genes among ESBL-producing Enterobacteriaceae isolates in Iran. African J Microbiol Res 6:5433–5439. doi:10.5897/AJMR11.017

    CAS  Google Scholar 

  • Nandagopal B, Sankar S, Sagadevan K et al (2015) Frequency of extended spectrum β-lactamase producing urinary isolates of gram-negative bacilli among patients seen in a multispecialty hospital in Vellore district, India. Indian J Med Microbiol 33:282–285. doi:10.4103/0255-0857.153563

    Article  CAS  Google Scholar 

  • Paterson DL, Bonomo RA (2014) Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 18:1–36

    Google Scholar 

  • Pitout JD, Sanders CC, Sanders WE (1997) Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli. Am J Med 103:51–59. doi:10.1016/S0002-9343(97)00044-2

    Article  CAS  Google Scholar 

  • Ponnusamy P, Nagappan R (2015) Molecular characterization of bla CTX-M, bla TEM, bla SHV- beta lactamase produced by uropathogenic Escherichia coli isolates. Int J Microbiol Res 6:67–73

    Google Scholar 

  • Ramanath KV, Shafiya SB (2011) Prescription pattern of antibiotic usage for urinary tract infection treated in a rural tertiary care hospital. Indian J Pharma Pract 4:57–63

    Google Scholar 

  • Rezai MS, Salehifar E, Rafiei A et al (2015) Characterization of multidrug resistant extended-spectrum beta-lactamase-producing Escherichia coli among uropathogens of pediatrics in North of Iran. Biomed Res Int. doi:10.1155/2015/309478

    Google Scholar 

  • Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY

  • Seyedjavadi SS, Goudarzi M, Sabzehali F (2015) Relation between blaTEM, blaSHV and blaCTX-M genes and acute urinary tract infections. J Acute Dis 5:1–6. doi:10.1016/j.joad.2015.07.007

    Google Scholar 

  • Shahcheraghi F, Nasiri S, Noveiri H (2009) Detection of extended-spectrum β-lactamases (ESBLs) in Escherichia coli, Iran. J Clin Infect Dis 4:65–70

    Google Scholar 

  • Shahid M, Singh A, Sobia F et al (2011) blaCTX-M, blaTEM, and blaSHV in Enterobacteriaceae from North-Indian tertiary hospital: high occurrence of combination genes. Asian Pac J Trop Med 4:101–105

    Article  CAS  Google Scholar 

  • Sharma M, Pathak S, Srivastava P (2013) Prevalence and antibiogram of extended spectrum β-lactamase (esbl) producing gram negative bacilli and further molecular characterization of ESBL producing Escherichia coli and Klebsiella spp. J Clin Diagn Res 7:2173–2177. doi:10.7860/JCDR/2013/6460.3462

    Google Scholar 

  • Shigemura K, Arakawa S, Miura T et al (2008) Significance of fluoroquinolone resistant Escherichia coli in urinary tract infections. Jpn J Infect Dis 61:226–228

    CAS  Google Scholar 

  • Tada DG, Gandhi PJ, Patel KN (2012) A study on antibiotic related resistance in UTI patients: a comparison between community acquired and hospital acquired E. coli. Natl J Community Med 3:255–258

    Google Scholar 

  • Thong KL, Lim KT, Yasin R et al (2009) Characterization of multidrug resistant ESBL-producing Escherichia coli isolates from hospitals in malaysia. J Biomed Biotechnol. doi:10.1155/2009/165637

    Google Scholar 

  • Weill FX, Demartin M, Tande D et al (2004) SHV-12 like extended spectrum β-lactamase producing strains of Salmonella enteric serotypes Babelsberg and Enteritidis isolated in France among infants adopted from Mali. J Clin Microbiol 42:2432–2437

    Article  CAS  Google Scholar 

  • Yu Y, Ji S, Chen Y et al (2007) Resistance of strains producing extended-spectrum beta-lactamases and genotype distribution in China. J Infect 54:53–57. doi:10.1016/j.jinf.2006.01.014

    Article  Google Scholar 

Download references

Acknowledgements

We are grateful to Prof. Dr. DK Roy, Dean, IMS and Sum Hospital (S‘O’A University) for extended essential laboratory facilities. Our sincere thanks are due to Prof. Dr. M.R. Nayak, Honourable President, Siksha ‘O’ Anusandhan University, Bhubaneswar, for providing financial support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Enketeswara Subudhi.

Ethics declarations

Conflict of interest

We declare that we have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jena, J., Sahoo, R.K., Debata, N.K. et al. Prevalence of TEM, SHV, and CTX-M genes of extended-spectrum β-lactamase-producing Escherichia coli strains isolated from urinary tract infections in adults. 3 Biotech 7, 244 (2017). https://doi.org/10.1007/s13205-017-0879-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13205-017-0879-2

Keywords

Navigation